Past infections may shape your COVID booster’s punch against Omicron

This in-depth study examines how previous immunity impacts the effectiveness of COVID-19 booster vaccinations and susceptibility to Omicron breakthrough infections. The research highlights the significant role of individual immune histories in shaping both humoral and cellular responses to SARS-CoV-2, urging for more tailored vaccine strategies.

New AI tool revolutionizes drug discovery for rare diseases

There are more than 7,000 rare and undiagnosed diseases globally.

September 25, 2024

‘Good’ Cholesterol and Dementia Risk; Water Allergy; Firearms Deaths Surge in Kids

Note that some links may require registration or subscription. Both high and low levels of HDL cholesterol in midlife were linked with an increased risk

October 6, 2023

Synendos set to study endocannabinoid inhibitor for neuropsychiatric conditions – Pharmaceutical Technology

Share this article Endocanninaboids are naturally occurring endogenous ligands that target cannabinoid receptors. Credit: Summit Art Creations via Shutterstock. Swiss company Synendos therapeutics has been

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.